T. Rowe Price Associates »

Crescent Biopharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.6M 304k 18.43
2025-12-31 $4.0M 338k 11.86
2025-09-30 $4.6M 384k 11.89

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
Tang Capital Management
Vanguard Capital Management
Logos Global Management
Deep Track Capital
Rtw Investments
Millennium Management
T. Rowe Price Associates

View all funds holding Crescent Biopharma